ActiPharma, Inc. recalls ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
- Recall date
- September 28, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- F-0463-2024
- FDA classification
- Class III
- Brand / firm
- ActiPharma, Inc.
- Sold / distributed
- Domestic distribution, in Puerto Rico.
Why it was recalled
FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
Get recall alerts
Free email alert whenever ActiPharma, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ActiPharma, Inc.